HKUMed Develops a Novel Cinnamaldehyde Nanomedicine for Rheumatoid Arthritis Treatment
July 13, 2024
July 13, 2024
HONG KONG, July 13 (TNSres) -- The University of Hong Kong issued the following news release:
A cross-institutional research team led by the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel cinnamaldehyde-based prodrug nanomedicine by utilising cinnamaldehyde, a common food additive, as an anti-inflammatory agent. The prodrug forms nanoparticles that deliver the therapeutic agents precisely to the inflamed sites, offering a solution for the treatm . . .
A cross-institutional research team led by the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel cinnamaldehyde-based prodrug nanomedicine by utilising cinnamaldehyde, a common food additive, as an anti-inflammatory agent. The prodrug forms nanoparticles that deliver the therapeutic agents precisely to the inflamed sites, offering a solution for the treatm . . .